Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older is ...

Healthcare providers, public health officials and policymakers need to develop a greater understanding of the serious health impact of pneumococcal disease in elderly adults. In addition to ...

Prevenar 13 is a mixture of the outer sugar coating (polysaccharide) from 13 different strains or serotypes of bacteria called Streptococcus pneumoniae ... higher than 39°C in babies or young ...

The pneumococcal vaccine can protect you from an infection caused by the bacteria Streptococcus pneumoniae or pneumococcus ... of vaccine called pneumococcal polysaccharide vaccine 23 (PPSV23 ...

Pneumonia is a Streptococcus pneumoniae (commonly known as "strep") bacterial infection, which is usually in your lungs. It can also be caused by the flu virus, the common cold virus, or a fungal ...

NA: Not applicable; PCV-7: 7-valent pneumococcal conjugate vaccine; PCV-13: 13-valent pneumococcal conjugate vaccine; PPV23: 23-valent pneumococcal polysaccharide vaccine.

Pneumococcal disease is caused by a specific type of bacterium called Streptococcus pneumoniae. It’s most common in children, but can also cause significant complications in older adults or ...